Panel discussion on the common challenges and hurdles that emerge when negotiating and executing IP based deals across technology and life sciences. Panel members will draw from real-life experience based on executed deals and cover a range of topics including:

• Bridging valuation gaps
• What’s critical to address in early term sheets/discussions to avoid lengthy renegotiations, i.e. “I thought we had a deal”, including
• License scope and retained rights of the licensor, i.e. “I didn’t mean to give that away”
• Uncertainty associated with performance milestones and measures
• Negotiation strategies and building in “room to give”
• Cross border issues